Journal of Internal Medicine Concepts & Practice››2021,Vol. 16››Issue (02): 84-87.doi:10.16138/j.1673-6087.2021.02.004
• Expert forum •Previous ArticlesNext Articles
Received:2021-03-07Online:2021-04-25Published:2022-07-26| [1] | Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study[J]. Lancet Respir Med, 2015, 3(4):310-318. doi:10.1016/S2213-2600(15)00043-0pmid:25682233 |
| [2] | 陈曦, 伍俊. 特发性肺纤维化的机制与治疗[J]. 生命的化学, 2020, 40(3): 329-336. |
| [3] | Li D, Wang B, Liu Y, et al. Prevalence and impact of comorbid obstructive sleep apnoea in diffuse parenchymal lung diseases[J]. PLoS One, 2021, 16(2): e0246878. doi:10.1371/journal.pone.0246878URL |
| [4] | Mavroudi M, Papakosta D, Kontakiotis T, et al. Sleep disorders and health-related quality of life in patients with interstitial lung disease[J]. Sleep Breath, 2018, 22(2): 393-400. doi:10.1007/s11325-017-1579-1pmid:29038949 |
| [5] | Pihtili A, Bingol Z, Kiyan E, et al. Obstructive sleep apnea is common in patients with interstitial lung disease[J]. Sleep Breath, 2013, 17(4): 1281-1288. doi:10.1007/s11325-013-0834-3pmid:23563999 |
| [6] | Zhang XL, Dai HP, Zhang H, et al. Obstructive sleep apnea in patients with fibrotic interstitial lung disease and COPD[J]. J Clin Sleep Med, 2019, 15(12): 1807-1815. doi:10.5664/jcsm.8090pmid:31855166 |
| [7] | Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med, 2011, 183(6): 788-824. doi:10.1164/rccm.2009-040GLURL |
| [8] | Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective[J]. Am J Respir Crit Care Med, 2002, 165(9): 1217-1239. doi:10.1164/rccm.2109080URL |
| [9] | Cardoso AV, Pereira N, Neves I, et al. Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease-characterization and treatment compliance assessment[J]. Can J Respir Ther, 2018, 54(2): 35-40. doi:10.29390/cjrt-2018-005URL |
| [10] | Lancaster LH, Mason WR, Parnell JA, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis[J]. Chest, 2009, 136(3): 772-778. doi:S0012-3692(09)60546-8pmid:19567497 |
| [11] | Şahin Duyar S, Uzel Şener M, Akıncı Özyürek B, et al. An integrated approach toward the clinical and polysomnographic characteristics of OSA accompanying IPF[J]. Turk Thorac J, 2020, 21(5): 334-339. doi:10.5152/TurkThoracJ.2020.19002URL |
| [12] | Heinzer RC, Stanchina ML, Malhotra A, et al. Lung vo-lume and continuous positive airway pressure requirements in obstructive sleep apnea[J]. Am J Respir Crit Care Med, 2005, 172(1): 114-117. doi:10.1164/rccm.200404-552OCURL |
| [13] | Sériès F, Cormier Y, Lampron N, et al. Increasing the functional residual capacity may reverse obstructive sleep apnea[J]. Sleep, 1988, 11(4): 349-353. pmid:2974620 |
| [14] | Chrousos GA, Kattah JC, Beck RW, et al. Side effects of glucocorticoid treatment[J]. JAMA, 1993, 269(16): 2110-2112. doi:10.1001/jama.1993.03500160080036URL |
| [15] | Bosi M, Milioli G, Fanfulla F, et al. OSA and prolonged oxygen desaturation during sleep are strong predictors of poor outcome in IPF[J]. Lung, 2017, 195(5): 643-651. doi:10.1007/s00408-017-0031-4URL |
| [16] | Kolilekas L, Manali E, Vlami KA, et al. Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis[J]. J Clin Sleep Med, 2013, 9(6): 593-601. doi:10.5664/jcsm.2758pmid:23772193 |
| [17] | Mermigkis C, Mermigkis D, Varouchakis G, et al. CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea-therapeutic difficulties and dilemmas[J]. Sleep Breath, 2012, 16(1): 1-3. doi:10.1007/s11325-010-0476-7URL |
| [18] | da Rosa DP, Forgiarini LF, Baronio D, et al. Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver[J]. Mediators Inflamm, 2012, 2012: 879419. |
| [19] | Weng T, Poth JM, Karmouty-Quintana H, et al. Hypoxia-induced deoxycytidine kinase contributes to epithelial proliferation in pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2014, 190(12): 1402-1412. doi:10.1164/rccm.201404-0744OCURL |
| [20] | Tiruvoipati R, Lewis D, Haji K, et al. High-flow nasal oxygenvshigh-flow face mask: a randomized crossover trial in extubated patients[J]. J Crit Care, 2010, 25(3): 463-468. doi:10.1016/j.jcrc.2009.06.050URL |
| [21] | Tarraubella N, Sánchez-de-la-Torre M, Nadal N, et al. Management of obstructive sleep apnoea in a primary carevssleep unit setting: a randomised controlled trial[J]. Thorax, 2018, 73(12): 1152-1160. doi:10.1136/thoraxjnl-2017-211237pmid:30064993 |
| [22] | Shepherd K, Hillman D, Holloway R, et al. Mechanisms of nocturnal gastroesophageal reflux events in obstructive sleep apnea[J]. Sleep Breath, 2011, 15(3): 561-570. doi:10.1007/s11325-010-0404-xpmid:20711680 |
| [23] | Mermigkis C, Bouloukaki I, Antoniou K, et al. Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis[J]. Sleep Breath, 2015, 19(1): 385-391. doi:10.1007/s11325-014-1033-6URL |
| [24] | Kohler M, Bloch KE, Stradling JR. Pharmacological approaches to the treatment of obstructive sleep apnoea[J]. Expert Opin Investig Drugs, 2009, 18(5): 647-656. doi:10.1517/13543780902877674URL |
| [25] | Canora A, Nicoletta C, Ghinassi G, et al. First description of the hyperpnea-hypopnea periodic breathing in patients with interstitial lung disease-obstructive sleep apnea: treatment implications in a real-life setting[J]. Int J Environ Res Public Health, 2019, 16(23): 4712. doi:10.3390/ijerph16234712URL |
| [26] | 姚娟娟. 无创呼吸机恒流模式的作用机制验证及舒适性评估[D]. 山东大学, 2020. |
| [27] | Gille T, Didier M, Boubaya M, et al. Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis[J]. Eur Respir J, 2017, 49(6): 1601934. doi:10.1183/13993003.01934-2016URL |
| [28] | 李庆云, 宋爱玲. 对特发性肺纤维化合并阻塞性睡眠呼吸暂停的新认识[J]. 中华医学杂志, 2019, 99(6): 416-418. |
| [1] | LI Zhen, PAN Lina, HU Jiaan, XU Zhihong.Clinical characteristics of 142 elderly patients with acute pulmonary embolism[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 379-384. |
| [2] | ZHANG Lulu, WU Qiannan, HUO Rujie, et al.Research progress of miRNA-206 on lung diseases[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 413-417. |
| [3] | QIU Liwen, XU Yiming, ZHANG Yin, SHEN Honghua, CHEN Shen.Evaluate therapeutic efficacy of resistance training and aerobic training for gerontal patients with chronic obstructive pulmonary disease[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 78-83. |
| [4] | .[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 97-101. |
| [5] | .[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(04): 276-281. |
| [6] | XU Lei, XU Yiming, SHEN Honghua, ZHANG Yin, REN Lei.The impact of comorbidity of stroke and obstructive sleep-hypopnea apnea on sleep, cognition and nerve function[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 97-102. |
| [7] | .[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 93-96. |
| [8] | .[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 88-92. |
| [9] | .[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 80-83. |
| [10] | .[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 76-79. |
| [11] | .[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 73-75. |
| [12] | .[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 134-137. |
| [13] | .[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 60-63. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
